OOIR: Observatory of International Research

Papers

(The H4-Index of Clinical Kidney Journal is 28. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)

Article	Citations
Obinutuzumab treatment for membranous nephropathy: effectiveness and safety concerns during the COVID-19 pandemic	462
Toward acid- and heparin-free dialysis: the regional anticoagulation approach	112
Microvascular perfusion, perfused boundary region and glycocalyx shedding in patients with autosomal dominant polycystic kidney disease: results from the GlycoScore III study	91
Can exercise improve outcomes for frail haemodialysis patients?	89
Interaction of general obesity and abdominal obesity with frailty in patients with chronic kidney disease: a nationally representative analysis	72
Use of eHealth and remote patient monitoring: a tool to support home dialysis patients, with an emphasis on peritoneal dialysis	57
Associations between depressive symptoms and disease progression in older patients with chronic kidney disease: results of the EQUAL study	56
Impact of the COVID pandemic on vascular access creation for haemodialysis in 16 Spanish haemodialysis centres	55
Correction to: Accelerated versus watchful waiting strategy of kidney replacement therapy for acute kidney injury: a systematic review and meta-analysis of randomized clinical trials	50
Probability of chronic kidney disease and associated risk factors in Chinese adults: a cross-sectional study of 9 million Chinese adults in the Meinian Onehealth screening survey	49
Non-invasive assessment of IgA nephropathy severity with [18F]AlF-NOTA-FAPI-04 PET/CT imaging	48
Alleviating symptoms in patients undergoing long-term hemodialysis: a focus on chronic kidney disease-associated pruritus	45
Association between frailty and bone health in early-stage chronic kidney disease: a study from the population-based CARTaGENE cohort	44
Informal caregiver burden in dialysis care and how it relates to patients’ health-related quality of life and symptoms	43
Efficacy and safety of telitacicept, a BLyS/APRIL dual inhibitor, in the treatment of IgA nephropathy: a retrospective case–control study	40
More dissimilarities than affinities between DNAJB11-PKD and ADPKD	39
A puzzling renal Fanconi Syndrome	38
Risk factors for steroid-induced osteonecrosis of the femoral head in children with immune kidney disease	34
Clinically meaningful eGFR slope as a surrogate endpoint differs across CKD stages and slope evaluation periods: the CKD-JAC study	34
The spectrum of diseases, genetic landscape and new mutation sites of hereditary cystic kidney disease	32
Plant-based diets for CKD patients: fascinating, trendy, but feasible? A green nephrology perspective	32
Causal relationships between immune cell phenotypes and primary glomerular diseases: genetic evidence from bidirectional Mendelian randomization study	32
Meet and greet but avoid the heat: a reflection on the carbon footprint of congresses prompted by ERA2023	32
The use of SGLT2 inhibitors and GLP-1 receptor agonists in older patients: a debate on approaches in CKD and non-CKD populations	31
Biomarkers in clinical epidemiology studies	30

Performance of the race-free CKD-EPI creatinine-based eGFR equation in a Danish cohort with measured GFR	29
Standardization of serum creatinine is essential for accurate use of unbiased estimated GFR equations: evidence from three cohorts matched on renal function	29
Donor-derived membranous nephropathy	29
Circulating miR-129-3p in combination with clinical factors predicts vascular calcification in hemodialysis patients	28
Successful treatment of calciphylaxis with vitamin K in a patient on haemodialysis	28
Cerebral blood flow following successful living kidney transplantation: the VINTAGE study	28